In Vitro Evaluation of the Safety and Efficacy of <i>Cibisatamab</i> Using Adult Stem Cell-Derived Organoids and Colorectal Cancer Spheroids.

Cancers (Basel) · 2025 · PMC11763756 · PMID 39858076

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

When directly comparing the cytotoxic effects of Cibisatamab across cancer spheroids and healthy organoids, we observed a clear trend of specific lysis in CEA high MKN-45 cancer spheroids and rectal organoids with intermediate CEA expression, while sparing DLD-1 spheroids and small intestinal organoids with lower CEA levels.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.